You are here

RAC Vaccines and Vaccination Group

Primary tabs

RAC Workgroup Efforts Focused on Vaccines and Vaccination

The Resilient American Communities (RAC) Vaccines and Vaccination Group is examining and acting on the issues surrounding vaccines development, distribution, vaccination logistics and execution, as well as vaccination strategy, safety, efficacy, trust, and hesitancy.  Special attention is currently focused on COVID-19 vaccines and vaccination. 

Members

Hank Rappaport Jan Booher John Girard Kathleen H mdmcdonald mike kraft

Email address for group

rac-vaccination@m.resiliencesystem.org

AstraZeneca commits to releasing more complete vaccine data after concerns from NIH

 

https://news.yahoo.com/astrazeneca-commits-releasing-more-complete-122835190.html

AstraZeneca acknowledged on Tuesday morning that a press release about its U.S. coronavirus vaccine trial was based on data through Feb. 17, and promised to release more complete results that are "consistent with" the interim data within the next 48 hours.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. Health Officials Question AstraZeneca Vaccine Trial Results

Federal health officials said early Tuesday that results from a U.S. trial of AstraZeneca’s Covid-19 vaccine may have relied on “outdated information” that “may have provided an incomplete view of the efficacy data,” casting doubt on an announcement on Monday that had been seen as good news for the British-Swedish company as well as the global vaccination drive.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. meat plant workers in many states are finally gettng vaccinations

Employees at food processing facilities, which had some of the country’s largest known coronavirus outbreaks early in the pandemic, are now eligible for vaccines in at least 26 states, a New York Times survey found.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OPINION: How can we get people to trust the AstraZeneca and other vaccines?

News Update: A U.S. trial found that AstraZeneca’s vaccine was 79 percent effective with no serious side effects, according to results released on Monday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 4.151 seconds.